Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ESTRELLA IMMUNOPHARMA, INC. (ESLA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ESTRELLA IMMUNOPHARMA, INC. (ESLA), most recent 12 months reported: net loss $10.01M. Latest balance sheet on file: liquid cash $1.38M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Denali Therapeutics Inc. · ELOXX PHARMACEUTICALS, INC. · enGene Therapeutics Inc. · ENTERA BIO LTD. · EXOZYMES INC. · GREEN PLANET BIOENGINEERING CO., LTD. · GREENLAND MINES LTD · Inhibikase Therapeutics, Inc.

Stock screener

Watchlist